Allscripts Healthcare Solutions Inc (MDRX)

MDRX (NASDAQ:Computer Software & Services) EQUITY
$12.79
pos +0.00
+0.00%
Today's Range: 12.65 - 13.08 | MDRX Avg Daily Volume: 2,139,800
Last Update: 06/23/17 - 4:00 PM EDT
Volume: 0
YTD Performance: 25.27%
Open: $0.00
Previous Close: $12.71
52 Week Range: $9.80 - $15.17
Oustanding Shares: 181,464,603
Market Cap: 2,306,415,104
6-Month Chart
TheStreet Ratings Grade for MDRX
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 9 9 8
Moderate Buy 1 1 2 2
Hold 8 8 7 8
Moderate Sell 0 0 0 0
Strong Sell 1 1 0 0
Mean Rec. 2.13 2.07 1.86 1.97
Latest Dividend: 5.23
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 10/13/08
Price Earnings Ratio: -48.88
Price Earnings Comparisons:
MDRX Sector Avg. S&P 500
-48.88 0.00 30.50
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
10.16% 1.27% -18.33%
GROWTH 12 Mo 3 Yr CAGR
Revenue 11.80 0.10 0.04
Net Income 0.00 -1.00 0.00
EPS 0.00 -0.80 0.00
Earnings for MDRX:
EBITDA 0.24B
Revenue 1.55B
Average Earnings Estimates
Qtr (06/17) Qtr (09/17) FY (12/17) FY (12/18)
Average Estimate $0.11 $0.13 $0.49 $0.58
Number of Analysts 10 10 10 3
High Estimate $0.12 $0.14 $0.52 $0.62
Low Estimate $0.10 $0.11 $0.47 $0.54
Prior Year $0.10 $0.11 $0.40 $0.49
Growth Rate (Year over Year) 15.00% 16.36% 21.75% 18.41%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands

bearishAllscripts Cut to Market Perform at Leerink

Jun 19, 2017 | 9:20 AM EDT

Leerink downgraded Allscripts to "Market Perform" with a $13 price target.

bullishAllscripts upgraded at Deutsche

Mar 27, 2017 | 7:30 AM EDT
MDRX was upgraded to Buy, Deutsche Bank said. $14 price target. Valuation call, as the company can deliver consistent growth over the next few years.

bullishAllscripts upgraded at Leerink

Aug 23, 2016 | 7:25 AM EDT
MDRX was upgraded to Outperform, Leerink Partners said. $17 price target. Core fundamentals are improving significantly.
By

Bruce Kamich

 | Dec 24, 2015 | 11:58 AM EST

Traders should go long on a close above $15.50

RMPIA
By

David Peltier

 | Jul 16, 2015 | 4:39 PM EDT

U.S. stocks returned to their winning ways on Thursday, headlined by Netflix and two IPOs.

bullishAllscripts upgraded at Piper

Apr 27, 2015 | 7:10 AM EDT

MDRX was upgraded from Underweight to Neutral, Piper Jaffray said. $12 price target. Investor sentiment is improving. 

bearishAllscripts Healthcare downgraded at Leerink

Feb 27, 2015 | 7:49 AM EST

MDRX was downgraded to Market Perform, Leerink Partners said. $13 price target. Company is seeing slower market demand. 

By

Timothy Collins

 | Feb 25, 2015 | 1:02 PM EST

And Cabot Oil is breaking out of a trading channel.

By

Dick Arms

 | Feb 15, 2015 | 10:00 AM EST

Previous trips to this level have failed to break higher.

By

Dick Arms

 | Jan 15, 2015 | 7:00 AM EST

The unusual action lately reinforces that idea.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.